Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [RETIRED]. - Goodin DS; Frohman EM; Garmany GP Jr; Halper J; Likosky WH; Lublin FD; Silberberg DH; Stuart WH; van den Noort S (Neurology, 2002)